FDA approves breakthrough CAR-T therapy for leukemia

August 31, 2017, 7:36 AM|
With FDA approval, breakthrough CAR-T therapy for cancer becomes the first approved gene therapy treatment in the U.S. It reprograms the body’s own immune system to attack a deadly type of blood cancer and has been effective in treating children and young adults with leukemia. Cancer expert Dr. David Agus joins “CBS This Morning” to discuss who’s eligible and the risks of treatment.

Add a Comment

Your email address will not be published. Required fields are marked *